Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-12 12:02 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | PRIMECAP MANAGEMENT CO | 10,253,500 14.53% | 192,000 (+1.91%) | View |
| 2021-02-11 5:25 pm Sale | 13G | CALITHERA BIOSCIENCES INC CALA | BIOTECHNOLOGY VALUE FUND L P | 4,361,238 6.2% | -2,729,400 (-38.49%) | View |
| 2021-02-10 10:39 am Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | VANGUARD GROUP INC | 3,674,694 5.21% | 3,674,694 (New Position) | View |
| 2021-01-28 5:55 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | BlackRock Inc. BLK | 5,668,400 8% | 1,560,890 (+38.00%) | View |
| 2021-01-25 4:06 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,000,000 5.67% | 2,500,000 (+166.67%) | View |
| 2020-10-08 7:01 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | PRIMECAP MANAGEMENT CO | 10,061,500 14.26% | 573,500 (+6.04%) | View |
| 2020-05-26 4:56 pm Sale | 13G | CALITHERA BIOSCIENCES INC CALA | BIOTECHNOLOGY VALUE FUND L P | 7,090,638 10.1% | -2,469,004 (-25.83%) | View |
| 2020-03-13 5:18 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | Point72 Asset Management L.P. | 3,240,046 5% | 3,240,046 (New Position) | View |
| 2020-02-14 2:44 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | BIOTECHNOLOGY VALUE FUND L P | 9,559,642 15.1% | 2,809,160 (+41.61%) | View |
| 2020-02-14 1:32 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | FEDERATED HERMES INC. FHI | 6,934,600 12.9% | 2,719,537 (+64.52%) | View |
| 2020-02-07 06:12 am Purchase | 13D | CALITHERA BIOSCIENCES INC CALA | DELPHI VENTURES VIII LP | 2,475,285 4.6% | 27,500 (+1.12%) | View |
| 2020-02-05 11:25 am Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | BlackRock Inc. BLK | 4,107,510 7.6% | 1,057,335 (+34.66%) | View |
| 2020-01-10 11:31 am Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | PRIMECAP MANAGEMENT CO | 9,488,000 15% | 9,488,000 (New Position) | View |
| 2019-11-08 09:01 am Sale | 13G | CALITHERA BIOSCIENCES INC CALA | WELLINGTON MANAGEMENT GROUP LLP | 581,272 1.08% | -3,127,386 (-84.33%) | View |
| 2019-06-25 4:49 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | BIOTECHNOLOGY VALUE FUND L P | 6,750,482 13.1% | 3,452,200 (+104.67%) | View |
| 2019-05-10 1:20 pm Purchase | 13G | CALITHERA BIOSCIENCES INC CALA | FEDERATED HERMES INC. FHI | 4,215,063 10.76% | 666,169 (+18.77%) | View |